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ABSTRACT The effectiveness of the
nonmetabolizable second messenger
analogue DL-myo-inositol 1,4,5-tris-
phosphorothioate (IPS3) described by
Cooke, A. M., R. Gigg, and B. V. L.
Potter, (1987b. Jour. Chem. Soc.
Chem. Commun. 1525-1526.) was
examined in triads purified from rabbit
skeletal muscle. A Ca2+ electrode
uptake-release assay was used to
determine the size and sensitivity of the
1PS3-releasable pool of Ca2+ in isolated
triads. Uptake was initiated by 1 mM
MgATP, pCa 5.8, pH 7.5 Release was
initiated when the free Ca2+ had low-
ered to pCa -7. We found that 5-25
,uM myo-inositol 1,4,5,-trisphosphate
(IP3), and separately IPS3, consistently
released 5-20% of the Ca2+ pool
actively loaded into triads. Single chan-
nel recording was used to determine if
ryanodine receptor Ca2+ release chan-
nels were affected by IPS3 at the same
myoplasmic Ca2+ and IPS3 concentra-
tions. Open probability of ryanodine
receptor Ca2+ release channels was
monitored in triads fused to bilayers
over long periods (200 s) in the
absence and following addition of 30
,uM IPS3 to the same channel. At myo-
plasmic pCa -7, IPS3 had no effect in
the absence of MgATP (P. = 0.0094 +
0.00 1 in control and P, = 0.01 ± 0.006
after IPS3) and slightly increased activ-
ity in the presence of 1 mM MgATP
(PO = 0.024 ± 0.03 in control and P0 =
0.05 ± 0.03 after IPS3). Equally small
effects were observed at higher myo-
plasmic Ca2+. The onset of channel
activation by IPS3 or P3 was slow, on
the time scale 20-60 s. We suggest
that in isolated triads of rabbit skeletal
muscle, 'P3-induced release of stored
Ca2+ is probably not mediated by the
opening of Ca2' release channels.
INTRODUCTION
In striated muscle, excitation-contraction coupling is ini-
tiated by the depolarization of the plasma membrane
which brings about the release of calcium from the
sarcoplasmic reticulum (SR). The factors that regulate
release from SR in vitro have been extensively docu-
mented (Martonosi, 1984), but the actual mechanism
that triggers the release in vivo remains conjectural. A
key component is the ryanodine receptor, a -565,000 Da
protein specific for the junction between the SR and the
transverse tubules (junctional SR). In the SR membrane,
the ryanodine receptor forms a channel which is responsi-
ble for Ca2+ and nucleotide-induced release, hence named
the Ca2" release channel (Smith et al., 1985, 1986a,b;
Imagawa et al., 1987; Lai et al., 1988; Smith et al., 1988;
Ma et al., 1988b). Predictions based on the primary
structure of the ryanodine receptor (Takeshima et al.,
1989) suggested that -90% of the protein protrudes from
the surface of the SR, presumably to form the "foot"
structure (Block et al., 1988; Wagenknecht et al., 1989)
that bridges the SR and the t-tubules. This large molecu-
lar mass may serve as a voltage sensor (if in close
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proximity to the t-system membrane) or as a binding site
for a second messenger, whereas the remaining 1O%
intramembrane segment may actually form the Ca2+
selective pore.
A model of excitation-contraction coupling involves the
action of the ubiquitous second messenger, myo-inositol
1,4,5-trisphosphate (IP3). Similar to the receptor-
mediated formation of 1P3 in smooth muscle (Somlyo et
al., 1988) it was suggested that 1P3 could be released from
the t-tubule membrane of striated muscle in response to a
depolarization (Vergara et al., 1985). According to this
hypothesis, IP3 would then diffuse across the gap that
separates the t-system from the SR and induce release by
opening a Ca2" channel in the SR (Vergara et al., 1985;
Volpe et al., 1985). There are numerous studies that have
dealt with the effect of 1P3 in striated muscle and have
reported negative results (Movsesian et al., 1985; Scherer
and Ferguson, 1985; Lea et al., 1986; Mikos and Snow,
1987; Palade, 1987; Pampe et al., 1988; Hanon et al.,
1988) or positive results (Volpe et al., 1985; Rojas et al.,
1986; Hidalgo et al., 1986; Donaldson et al., 1987; Nosek
et al., 1987). A serious limitation to the IP3 hypothesis is
the time course of contractions evoked by IP3 (Walker et
al., 1987) which were found to be too slow to underlie
excitation-contraction coupling in fast twitch muscle. On
the other hand, direct support has come from the mea-
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surement of lP3-mediated opening of Ca2" release chan-
nels in the SR membrane of frog skeletal muscle (Suarez-
Isla et al., 1988).
In this report we tested the ability of a nonmetaboliz-
able analogue of 1P3, namely DL-myo-inositol 1,4,5-
trisphosphorothioate (IPS3, Cooke et al., 1 987b; Nahorski
and Potter, 1989), to release actively-accumulated Ca2"
and to open release channels in triads of rabbit skeletal
muscle. Previous studies showed that IPS3 is resistant to
5-phosphatase activity (Hamblin et al., 1987; Willcocks
et al., 1988; Taylor et al., 1989) while being only three-
fold less potent than lP3 in its ability to release Ca2" from
intracellular stores in many nonmuscle cells (Strupish et
al., 1988; Taylor et al., 1988, 1989). By using IPS3 we
thought to separate the effects of 1P3 from those of other
phosphoinositides in the PI cascade (Nahorski and Potter,
1989) and to discard IP3 hydrolysis by endogenous 5-
phosphatases as one source of negative results (Somlyo et
al., 1988). The significant observation is that IPS3 consis-
tently released up to 20% of the actively-loaded Ca2"
pool, but under the same conditions activation of Ca2+
release channels was none or minimal. This result raises
the possibility that the Ca2'-mobilizing activity of 1P3 or
IPS3 in rabbit triads may not be mediated by ryanodine
receptor Ca2+ release channels but by other channels or
mechanisms yet unidentified.
MATERIALS AND METHODS
Purification of triads
Triads were isolated from rabbit skeletal muscle as described by
Mitchell et al. (1983), using the pyrophosphate variant. White muscle
from the back and hind legs was minced and ground in a food processor.
Each of 4-5 portions of 40 g were homogenized for 60 s in 300 ml of 0.3
M sucrose, 0.5 mM EGTA, 20 mM Na4P2O7, 20 mM NaH2PO4, 1.0
mM MgCl2, pH 7.1, using a blender (Waring Products Div., New
Hartford, CT) at maximum speed. The following protease inhibitors
were added during homogenization: Pepstatin A (1 uM), lodoacetamide
(1 mM), PMSF (0.1 mM), Leupeptin (1 AM), and Benzamidine (1
mM). The homogenate was spun for 15 min at 9,000 g in a Sorvall GSA
rotor (DuPont Instruments, Hoffman States, IL). The supernatant was
filtered and centrifuged at 14,000 g for 30 min in the same rotor. Pellets
were resuspended to a final volume of 60 ml in the same medium used
for homogenization and layered on top of a step sucrose gradient
composed of 7 ml of 27% wt/vol sucrose, 7 ml of 32% sucrose, 14 ml of
38% sucrose, in 20 mM Na4P207, 20 mM NaH2PQ4, 1 mM MgCl2, pH
7.1. Gradients were centrifuged for 16 h at 20,000 g in a rotor (model
SW; Beckman Instruments, Inc., Fullerton, CA) at 40C. The triad
fraction was collected from the 32-38% sucrose interface. After gentle
dilution with 3 vol of homogenization medium without sucrose, a pellet
was obtained by centrifugation at 30,000 g for 40 min using a Beckman
Instruments, Inc. 35 rotor. Triads were resuspended in 0.3 M sucrose, 5
mM Hepes-KOH, pH 7.0, aliquoted, frozen in liquid nitrogen, and
stored at -800C until use. Routinely, the [3H]PN200-1 10 binding
capacity was 12 pmol/mg, the [3H]Ryanodine binding capacity was 9
pmol/mg, and the maximum ATP-dependent Ca2" uptake capacity was
15 nmol/mg triad protein.
Ca2+ release measurements
Ca2` uptake and release were assayed in a volume of 1 ml at 300C using
a Ca2"-selective electrode (Orion Research, Inc., Cambridge, MA).
Uptake medium was 150 mM KCI, 2 mM MgCl2, 50 mM Mes-Tris pH
7.5. Electrodes were calibrated using Ca-EGTA buffers prepared in
uptake medium. A computer program was used to determine the free
Ca2+ concentration using stability constants of Fabiato and Fabiato
(1978). Voltage output from the electrode was digitized at 10 points/s
and stored on an IBM/PC using Kiethley software (Cleveland, OH).
Triads (4 mg/ml) were preincubated for 60 min at 0°C in uptake
medium and diluted 20-fold in the electrode vessel (1 ml) which
contained uptake medium plus 5 gM free Ca2". Temperature was kept
at 300C with a recirculating temperature-controlled water bath. Triad
suspension in the vessel was vigorously stirred. Calcium uptake was
initiated by the addition of 1 mM ATP-KOH pH 7.5. Upon completion
of the uptake and leveling of the voltage signal (a typical 16-mV shift),
IPS3 or IP3 were added from a 1-mM stock solution in uptake medium
without Ca2". ATP, IPS3, or IP3 alone had no effect on electrode
readings. A total of eight separate triad preparations were tested.
Planar bilayer recordings
Planar bilayers were composed of brain phosphatidylethanolamine and
brain phosphatidylserine at a 1:1 weight ratio dissolved in decane. These
were formed on a 0.3 mm diam hole in a Lexan cup. Triads preparations
(0.1-0.2 mg) were added to the cis solution composed of 0.25 M CsCl,
10 ,M CaC12, and 10 mM Hepes-Tris pH 7.5. The trans solution was
the same except the CsCl which was 0.05 M (Cs+ instead of Ca2, was
the major carrier of current). Solutions were connected via an Ag/AgCl
electrode and an agar/KCI bridge to a List L/M EPC 7 amplifier (List
Electronic, Darmstadt, FRG). Trans solution was held at ground.
Recordings were filtered through a low-pass Bessel filter (Frequency
Devices, Haverhill, MA) at a front panel setting of 1.5 kHz and
digitized at 4 kHz. Acquisition, storage, and analysis were done on a
PC/AT computer using Keithley software (Cleveland, OH). The total
recording time was - 120 min from three preparations of triads.
Chemicals and abbreviations
Phospholipids were purchased from Avanti Polar Lipids (Birmingham,
AL). NaATP was purchased from Sigma Chemical Co. (St. Louis,
MO). lonophore A23187 and ryanodine were purchased from Calbio-
chem (La Jolla, CA). Sucrose, salts, and buffers were reagent grade
(Fisher Scientific Co., Pittsburgh, PA; Behring Diagnostics, San Diego,
CA). CsCl was analytical grade (Johnson Matthey Co., Hereforshire,
England). DL-1P3 and DL-IPS3 were synthesized as described (Cooke et
al., 1987a,b) and were purified by ion exchange chromatography on
DEAE Sephadex A-25. The concentration of D-(1,4,5)IP3 or D-
(1,4,5)1PS3, and not that of the racemate are reported in all experi-
ments. Abbreviations were as follows, ATP(adenosine 5' trisphosphate);
EGTA (ethylenediamine tetraacetic acid); Hepes (N-2-hydroxyethylpi-
perazine-N'-2-ethanesulfonic acid); IP3 (DL-myo-inositol 1,4,5-tris-
phosphate); IPS3 (DL-myo-inositol 1,4,5-trisphosphorothioate); Mes
(2N-Morpholino ethanesulfonic acid); PMSF (phenylmethylsulfonyl
fluoride); Tris (Tris-hydroxymethyl aminomethane).
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RESULTS
lP3-induced release of Ca2+ in
triads of skeletal muscle
Triads derived from the t-tubule SR junction of skeletal
muscle can be purified without apparent loss of structural
integrity and with retention of Ca2` uptake capacity
(Ikemoto et al., 1984; Caswell et al., 1979; Mitchell et al.,
1983). We previously used this preparation as a conve-
nient source of functional ryanodine receptors (Imagawa
et al., 1987; Ma et al., 1988b; Smith et al., 1988; Valdivia
et al., 1989, 1990). Fig. 1 describes the release of Ca2`
induced by IP3 and IPS3 in a suspension of triads. Ca2"
[Ca++], Mm
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FIGURE 1 lP3 and IPS3-induced Ca2" release in triad vesicles measured
with a Ca2" electrode. Uptake corresponds to a downward deflection
(decrease in solution free Ca2") and release to an upward deflection
(increase in solution free Ca2"). Left scales give calibrated free Ca2".
(Top) Ca2" uptake was initiated by 1 Mmol at ATP-KOH (arrow) added
to a volume of I ml containing 150 mM KCI, 2 mM MgCl2, 5 ,uM Ca2",
50 mM Mes-Tris, pH 7.5 and 200 Mg triad protein. Release was initiated
by 25 nmol of IP3 (arrow). Subsequent additions of 1 Mmol of ATP-
KOH are indicated by arrows. Voltage and time marks are 2 mV and 90
s. (Bottom) Ca2" release induced by 25 gM lP3 or 25MuM IPS3 from two
separate experiments are compared on expanded scales. Voltage and
time marks are 1 mV and 30 s.
was actively loaded into the SR via the Ca2" pump as
described (Miyamoto and Racker, 1982). Low free Ca2"
(<3 ,um) was used during the uptake phase so that the
free Ca2, concentration at the moment of release would
be within the resting range of myoplasmic Ca2+,
-0.1-0.2
,uM. Uptake, shown as a downward deflection in the top
trace of Fig. 1, was always initiated by the addition of 1
,umol ATP-KOH pH 7.5 (1 mM final concentration) after
equilibration of 200 Ag triad protein in 1 ml of 150 mM
KCl, 2 mM MgCl2, 5 ,uM total CaCl2, 50 mM Mes-Tris,
pH 7.5. The average decrease in free Ca2, was from 1.8 ±
0.19 ,uM Ca2, (±SD, n = 12) to 0.2 ± 0.01 ,uM Ca2,
(±SD, n = 12) in -25 s with an initial rate of 18 nmol
Ca2,/mg triad protein/min. The absolute voltage of the
Ca2+-sensitive electrode was - 117 ± 3 mV (n = 11) and
- 131 ± 3 mV (n = 11) before uptake and at the end of
the uptake period, respectively. The total Ca2+ accumu-
lated during the uptake, measured 2 min after the addi-
tion of ATP, was 10.5 ± 2.7 nmol Ca2+/mg triad protein
(n = 8). After uptake, free Ca2+ remained constant below
-0.2 ,uM for up to 200 s and then slowly returned to
micromolar levels with a t-/2 - 250 s (not shown). This
was presumably due to a slow leakage of vesicular Ca2,
after ATP consumption. The following controls, i)
through vi) (not shown, see Valdivia et al., 1989a),
ensured that the observed Ca2, waveforms in Fig. 1 were
due to sequestration of Ca2, via the SR Ca2+ pump and to
release of Ca2, from the interior of sealed vesicles. i)
Uptake could be initiated by 1 mM ATP but not by the
same concentration of the non-hydrolyzable analogue
AMP-PMP; ii) the duration of the uptake phase was
increased -five-fold by addition of 5 mM creatine phos-
phate and 50 units creatine kinase as an ATP-regenerat-
ing system; iii) free Ca2, could be increased to pre-ATP
levels by addition of 1,uM of the Ca2+-ionophore A23187;
iv) uptake was not affected by 10 ,uM oligomycin, the
mitochondrial ATP-ase inhibitor; and v) uptake was
decreased by the Ca2' release channel-specific alkaloid
ryanodine, at concentrations of 1-100 ,uM; vi) no release
was observed when IP3 or IPS3 were added in the absence
of ATP or in triads incubated with Ca2' and ATP but in
the presence of Ca2+ ionophore A23187.
The top and bottom panels of Fig. 1 show that 25 ,uM
D-1P3 or D-IPS3 added as 50 ,uM DL-racemate were
equally effective in releasing a fraction of the ATP-
dependent Ca2" sequestered into triads. The IP3 and IPS3
used in all experiments contained equal amounts of
D-(1,4,5) and L-(1,4,5) isomers of which only the D-
(1,4,5) isomer was previously shown to be biologically
active (Taylor et al., 1988, 1989; Strupish et al., 1988).
Accordingly, we reported the concentration of D-
(1,4,5)lP3 or D-(1,4,5)IPS3, and not that of the racemate.
As shown in Fig. 1 (top), successive additions of 1 ,tmol
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ATP-KOH, after addition of 1P3, could stimulate a net
reuptake of Ca2". Although the total Ca2" released by 1P3
or 1PS3 was approximately the same, the overlapped
traces in Fig. 1 (bottom) indicated that IPS3 elicited
release at a slightly higher rate. Total release at different
doses of 1PS3 is shown in Fig. 2. Approximately 20% of
the sequestered Ca2" was released at a concentration of
25 ,uM whereas 3-5% was released at 5 ,M. The concen-
trations of IPS3 that mobilized SR Ca2" were 5 to 10-fold
higher than previously used in three other cell lines. In
Swiss 3T3 cells D-(1,4,5)IP3 and DL-(1,4,5)IPS3 released
-50% of the intracellular Ca2" pool with EC50s of 0.7 ,AM
and 5 ,AM, respectively (Taylor et al., 1988). In hepato-
cytes, 60% of the Ca2, pool was mobilized with EC50s of
0.4O,M and 2.1 ,uM, respectively, whereas in GH3 cells,
the EC50s for the same compounds were 0.22 ,uM and 3
,uM, respectively (Strupish et al., 1988). It has been
argued that a strong hydrolysis of IP3 by endogenous
5-phosphatases could explain the low effectiveness of
exogenously added 1P3 in some fragmented or in vivo
muscle preparations (Hidalgo et al., 1986; see Somlyo et
al., 1988 for a review). We discarded this possibility
because the amount of Ca2+ released by 1PS3 was the
same as that released by 1P3.
Effect of 1P3 and IPS3 on Ca2"
release channels at micromolar
cytosolic Ca2+
To identify the mechanism of release we tested the effect
of 1P3 and IPS3 on the Ca2` release channel described by
Smith et al., (1985, 1988). Recordings were made using a
gradient of CsCl as current carrier, as described previ-
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FIGURE 2 Doses of IPS3 required to induce Ca2" release in actively-
loaded triads. Triads were actively loaded at constant protein (200
Mg/ml), MgATP, and free Ca2" described in Fig. 1 and text. The free
Ca2+ concentration in the reaction medium averaged 2.0 ± 0.5 /M
before uptake and 0.25 ± 0.05 MM after completion of uptake (n - 22
experiments). Bars represent mean and 1 SD for the number of
experiments indicated in parentheses. Ca2" release (%), corresponds to
the percentage of the Ca2, uptake which is released by IPS3. Ordinate
gives concentration of the D-(1,4,5)IPS3 isomer.
ously (Vilven et al., 1989; Valdivia et al., 1990). 250 mM
CsCl was present on the cis solution and 50 mM CsCl, on
the trans solution. Both solutions were buffered to pH 7.4
with 10 mM Hepes-Tris and to pCa 5 with 10 mM
Ca2EGTA buffers. The use of CsCl permitted the block-
ade of SR K+ channels (Coronado and Miller, 1979) and
allowed Ca2, to be maintained within a physiological
range on either side of the channel. Dihydropyridine-
sensitive L-type Ca2, channels present in the transverse
tubule of triads (Valdivia et al., 1990) would conduct Cs'
when Ca2, is maintained in the micromolar range (Cor-
onado and Smith, 1987). However, their contribution to
the recordings was discarded because the conductance of
L-channels is -10 times smaller than that of release
channels and because the activity of L-channels in planar
bilayers is dependent on the constant presence of Bay
K8644 dihydropyridine agonist. Observations (a)
through (d) described below, established that Ca2,
release channels were functional in CsCl solutions. (a) In
cis 250 mM CsCl and trans 50 mM CsCl, release
channels had a linear current-voltage relationship with a
slope conductance of 450 pS and a reversal at potentials
more negative than -30 mV. This result is the same as in
a study of purified ryanodine receptors from rabbit heavy
SR (Smith et al., 1988); (b) 10 MM ryanodine produced
an irreversible decrease in conductance to 250 pS and an
increase in mean open time from 0.5 ms in control to 50
ms in the presence of ryanodine; (c) Cis Ca2, increased
channel activity from P. = 0.002 ± 0.002 at pCa = 9 to
P0 = 0.4 ± 0.1 at pCa 6; further increase in cis Ca2,
decreased channel activity to P0 = 0.01 ± 0.01 at pCa 3.
This result is in excellent agreement with 45Ca efflux
measurements in heavy SR vesicles (Meissner, 1986); (d)
Cis 5 mM ATP increased channel activity -five-fold, cis
1 mM free Mg2' decreased activity 10-fold, and cis 1 ,uM
ruthenium red decreased activity 100-fold. These results
are the same reported previously using high trans Ca2+ as
current carrier in heavy SR fused to planar bilayers
(Smith et al., 1986a,b). Fig. 3 A and Fig. 4 A show
activity of single release channels at + 20 mV, 10 ALM free
Ca2+ (labeled control pCa 5) and the same channels after
addition of 30 MM 1P3 (Fig. 3 A, labeled 1P3 pCa 5) or 30
MuM 1PS3 (Fig. 4 A, labeled 1PS3 pCa 5). At this concen-
tration, which was the highest tested in the uptake and
release experiments of Fig. 2, 1P3 and IPS3 produced a
modest increase in bursting activity.
To describe the kinetic effect of both phosphoinositides
quantitatively, channels were monitored during relatively
long periods (80-100 s) during control and after addition
of 30 MuM IP3 or IPS3. The data showed that the increase
in bursting activity translated into a small increase in the
total time in which channels spent open. The open proba-
bility, P., was calculated from peak current histograms
(see Fig. 2 of Ma and Coronado, 1988a) and corresponds
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FIGURE 3 Effect of 1P3 on Ca2" release channels activated by 10 giM Ca2". (A) through (D) are from the same experiment. (A) Representative
traces at a holding potential of 20 mV and 10uM cis free Ca2" before (labeled control pCa 5) and after (labeled 1P3 pCa 5) addition of cis 30 ,uM IP3.
(B) PO measured every 100 ms appears as a bar of length 0 to 1. Empty spaces represent 100-ms sweeps without openings. Average P0 from the entire
recording is shown for control and test periods. (C) The cumulative sum of PO measured every 5 s appears continuously as a function of recording time;
t = 0 corresponds to the beginning of the control period or to the time immediately after addition of IP3. (D) % of open events of duration time t, or
longer are plotted as a function of time, t. Total events are n - 2057 for control and n - 6252 following addition of IP3.
to the fraction of total digitized current falling within 4
SD above and below the mean amplitude of the open
channel. In the experiment of Fig. 3 A, P. was 0.098 in
control and 0.173 after addition of 30 ,uM IP3, whereas in
Fig. 4 A, P0 was 0.099 in control and 0.167 after addition
of 30 AM IPS3. Clearly the level of activation produced by
either compound was the same in each case, -60% above
control. Panels B in Figs. 3 and 4 describe the appearance
of events during the 80-100 s that lasted each recording.
The bars of length 0 to 1 indicate open probability on a
sweep by sweep basis (100 ms/sweep). There was an
obvious clustering of events in time either in controls or
after addition of IP3 or IPS3. Clusters of events or bursts
were operationally defined as a collection of sweeps
containing openings flanked by at least one sweep without
openings. Either in Fig. 3 B or Fig. 4 B there was a clear
increase in the number of bursts per unit time after
addition of the phosphoinositide. However, a plot of
cumulative P0 shown in Fig. 3 C and Fig. 4 C revealed that
this effect was not instantaneous but developed 30-40 s
after exposure of channels of IP3 or IPS3. Thus, the
kinetic effect of IP3, and similarly IPS3, was not only
small but also sluggish. Despite the increase in P0, we
found that the mean open time, fitted from the time
histograms (Figs. 3 D and 4 D), actually remained the
same or it decreased but it did not increase. In controls
and in the presence of IP3 or IPS3, the exponential fitting
of the distributions of open events required two time
constants. A fast time constant, r1, was necessary to fit the
brief and mostly unresolved events <2 ms, and a slower
time constant, r2, was needed to fit events .5 ms. In Fig. 3
D, the time constants that best described the histogram
were rT = 1.9 ms and r2 = 13 ms in control; and 71 = 1.4
ms and r2 = 4.6 ms during the 80-s period after addition
of 30 IAM IP3. In Fig. 4 D, rl = 1.1 ms and r2 = 7.8 ms in
control; and rl = 1. ms and T2 = 7.0 ms during the 80-s
period after addition of 30 ,uM IPS3. A summary of the
kinetic data averaged from three separate experiments
under the same conditions that tested IPS3 are shown in
Table 1. The most significiant effects were a shortening of
the mean open time, a shortening of the mean closed time,
an increase in the total number of events, and an increase
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FIGURE4 Effect of IPS3 on Ca2" release channels activated by 10 gM Ca2". (A) through (D) are from the same experiment. (A) Representative
traces at a holding potential of 20 mV and 10MgM cis free Ca2" before (labeled control pCa 5) and after (labeled IPS3 pCa 5) addition of cis 30 ,uM
IPS3. (B) through (D) are the same as in Fig. 3. (D) Total events are n - 2648 for control and n - 5580 following addition of IPS3.
in the mean duration of bursts. Thus, the effects of IPS3
are complex and probably occur by modification of sev-
eral kinetic steps. However, the average P0 computed
from three separate recordings changed only slightly from
0.12 ± 0.03 in control to 0.19 ± 0.03 after addition of 30
,uM IPS3. P. of control and IPS3 were not equal to a level
of significance t < 0. 1.
Small effect of IPS3 at
submicromolar cytosolic
Ca2+ plus MgATP
The lack of a larger effect of IPS3 on the PO could have
resulted from the relatively high cis Ca2" used to activate
channels during control because binding of IP3 to its
receptor, at least in brain, is actually inhibited by micro-
molar Ca2" (Worley et al., 1987). We therefore repeated
the same recordings above at pCa 7. In Fig. 5, control
activity was first recorded at pCa 5 and this was followed
by the lowering of cis free Ca2" to pCa 7 using a
calibrated solution of EGTA. Control activity at this
lower Ca2" resulted in a decrease in channel open proba-
bility of -six-fold due to the Ca2" dependence of the
release channel (Smith et al., 1986a; Vilven et al., 1989).
Following the test period, the cis free Ca2" concentration
was increased to confirm that an active channel was
present in the bilayer even though IPS3 was unable to
open it. In Fig. 6, control in pCa 5 was followed by
addition of ATP and Mg2" which resulted in a decrease in
PO and a decrease in open channel current due to Mg2"
blockade (Smith et al., 1986a). Mg2" and ATP were
added to simulate the ligand conditions used in uptake
and release experiments in Fig. 1. However, either in the
absence of Mg2" and ATP (Fig. 5) or in the presence of
Mg2+ and ATP (Fig. 6), 30 ,M IPS3 had virtually no
effect on the P0 of release channels. This is described
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TABLE 1 Kinetic effect of IPS3 on calcium release
channels of rabbit skeletal muscle triads
Control 30 gM IPS3
Recording time ms 292,500 308,750
Number of open events 9,553 18,131
Mean open time Tr, ms 1.6 ± 0.4 1.4 ± 0.2
T2,ms 12.5 ± 3.8 8.2 ± 3.5
Mean closed time Tr, ms 2.6 ± 0.78 1.6 ± 0.2
T2, ms 36.7 ± 11.5 29.5 ± 6.9
Fraction open time P0 0.12 ± 0.03 0.19 ± 0.03
Number of bursts 272 343
Mean burst duration t,, ms 38.4 ± 19.6 45.9 ± 19.7
t2,ms 776 ± 217 728 ± 150
Fraction burst time 0.27 ± 0.12 0.35 ± 0.12
Mean ± SD are from three separate recordings at a holding potential of
+20 mV and cis 10 iM free Ca2". Records were filtered at 1.5 KHz and
digitized at 4 KHz. Openings were identified by two threshold detectors
placed between baseline and open current levels. Burst were identified as
one or more openings flanked by closings of duration >50 ms. Fraction
of open time or burst time corresponds to the probability of occurrence
of an open event or burst event within the recording period. Recording
time in each experiment was exp. 1 control 97.5 s, exp. 1 test 97.5 s; exp.
2 control 130 s, exp. 2 test 130 s; exp. 3 control 66 s, exp. 3 test 82.5 s.
CONTROL pCa 5
|~~~ ~~AX ilA
pCa 7
IPS3 pCa 7
-L4-1- -k l~--nil M4A -ol
pCa 5.7
25 pA
200 ms
quantitatively by the bar histograms next to each record-
ing, and by the P0 calculated for each condition. In three
recordings such as in Fig. 5, P0 averaged 0.0094 ± 0.001
in control pCa 7 and 0.01 ± 0.006 after addition of IPS3.
In three recordings such as in Fig. 6, P0 averaged 0.024 +
0.03 in control pCa 7 and 0.05 ± 0.03 after addition of
IPS3. A test for two means of independent samples was
used to establish if the P0 of control and that following
IPS3 were unequal for a specified level of significance, t.
In the absence of MgATP, P0s of control and following
IPS3 were not unequal for all levels of significance t < 0. 1.
In the presence of MgATP, P0s of control and following
IPS3 were unequal for a level of significance t 2 0.1 but
could not be demonstrated to be unequal for a level of
significance t < 0.05.
DISCUSSION
Because Ca2" release channels are the major Ca2" con-
ductance pathway of the junctional SR of skeletal muscle,
the issue of whether they mediate 'P3-induced Ca2"re-
lease is important to resolve. Based on a comparison of
45Ca2" flux density and single channel open probability,
we estimated previously a minimum number of three
l PO -0.061
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FIGURE 5 Effect of IPS3 on Ca2" release channels held closed by submicromolar Ca2". (Left) Representative traces following sequential additions to
the cis chamber, shown from top to bottom. All traces from the same experiment. (Right) P. measured every 100 ms is shown for 80 s following each
addition. Average P. during each 80-s period is indicated. Control activity was in cis 10 uM free Ca2", pH 7.4. Free Ca2" was next lowered to pCa 7
with cis 30,uM K2EGTA pH 7.4. Cis 30,MM IPS3 was next added. Free Ca2, was next raised to pCa 5.7 with cis 41.6MUM CaCl2. Holding potential was
20 mV in all records.
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FIGURE 6 Effect of IPS3 on Ca2" release channels held closed by submicromolar Ca2" plus MgATP. (Left) Representative traces following
sequential additions to the cis chamber, shown from top to bottom. All traces from the same experiment. (Right) P. measured every 100 ms is shown
for 60 s after each addition. Average PO during each 60-s period is indicated. Control was cis 10MM free Ca2", pH 7.4, Cis 1 mM total ATP and 2 mM
total MgCl2 were next added. Free Ca2, was next lowered to pCa 7 with cis 300 MM K2EGTA pH 7.4. Cis 30 MM IPS3 was next added. Holding
potential was 20 mV in all records.
channels per each junctional SR vesicle in -90% of the
vesicle population and a density of -20 channels/As2
(Smith et al., 1986b). This large density and the large
unitary conductance of release channels raised the possi-
bility that even the small changes in P0 observed upon
addition of 1PS3 (from 0.019 to 0.046 in Fig. 6), could be
sufficient to explain the release of the -20% of Ca2"
actively stored into triads (Fig. 1). For this explanation to
be consistent with Fig. 1, it would be necessary to assume
(a) that the steady-state level of intravesicular Ca2", seen
at the end of the uptake period, is set by an equal Ca2"
pump and leak rates; (b) that upon addition of IPS3, a
lower steady-state level of intravesicular Ca2" is set by an
increase in the leak rate, i.e., a more active Ca2" release
channel; and (c) that in the presence of 1PS3, the pump
rate can overcome the leak rate if sufficient ATP is
present. The latter would explain the recovery of intrave-
sicular Ca2" when ATP is increased in a dose-dependent
manner after release by 1PS3 (Fig. 1, top).
Comparison of influx and efflux
rates of Ca2+ in triads
Although assumptions (a) through (c) are generally
valid, a straightforward calculation given below shows
that the efflux rate through the total population of release
channels in our preparation of triads is 1O' times larger
than the influx rate of Ca2" via the Ca2" pump measured
experimentally. Thus, a finely tuned balance between
influx and efflux rates that would satisfy (a) through (c)
is unlikely to be set by Ca2" release channels given their
high density in triads and prodigious turnover rate. The
total Ca2+ efflux through Ca2" release channels in the
population of triads can be estimated with a minimum
number of assumptions as,
Je = inP0/zF, (1)
where J' has units of moles of Ca2+/s/mg triad protein; i
is the single channel Ca2" current at the operating SR
voltage and intravesicular Ca2" concentration; F is Fara-
day's constant; z is the valence; n is the density of
channels per mg triad protein; and P. is the open probabil-
ity per channel. The single channel current is a function of
voltage, V, and is calculated in terms of the channel
equilibrium potential as,
(2)
where 'ycC is the Ca2+ conductance at a given concentra-
tion of intravesicular Ca2", and Veq is the reversal poten-
tial of the release channel under the ionic gradients set
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across the SR. yca is estimated from the Ca2" binding
isotherm described for the ryanodine receptor (Smith et
al., 1988) given by,
YCa = Ymax/[l + Kd/(Cai) 1] (3)
where ymax is the saturating Ca2' conductance, Kd is the
Ca2" binding affinity, and [Ca;] is the intravesicular Ca2+
concentration. We assumed [Cai] = 5 mM for the intrave-
sicular concentration during constant pump activity (see
Hasselbach and Oetliker, 1983). They. and Kd, deter-
mined previously from single channel experiments, were
172 pS and 3 mM, respectively (Smith et al., 1988). The
Ca2` conductance of a single release channel (Eq. 3) is
'yCa = 108 pS. To estimate the single channel current (Eq.
2) we assumed no voltage drop across the triad mem-
brane, V = 0 mV (see Hasselbach and Oetliker, 1983)
and Vq = 5 mV determined previously in physiological
solutions, i.e., cis 150 mM KCI, 10 uM Ca2+ and trans
150 mM KCI, 5 mM Ca2+ (Smith et al., 1988). The Ca2+
current per single open channel (Eq. 2) is i = 0.54 pA.
The number of channels expressed in milligrams of triad
protein is directly obtained from [3H]Ryanodine binding
studies in the same preparation. The estimated ryanodine
receptor density was 9 pmol/mg triad protein (Valdivia et
al., 1990). Assuming one active channel per ryanodine
binding site (Imagawa et al., 1987), n = 5.4 x 1012
channels/mg triad protein. Thus, for a typical activation
of release channels by IPS3 such as in Fig. 6, where PO
(test minus control) 0.027, we estimated the Ca2+
efflux rate through release channels in the population of
triads (Eq. 1) to be J' = 0.41 ,umol Ca2+/s/mg triad
protein. This efflux is three orders of magnitude larger
than the initial rate of Ca2+ influx during ATP-dependent
activation of the SR Ca2+ pump in our preparation or J' =
0.3 nmol Ca2+/s/mg triad protein (calculated from Fig. 1
and indicated in text).
This gross mismatch between Ca2+ influx via the Ca2+
pump and efflux via release channels has important
consequences. Based on this calculation, for example, the
recovery of uptake after the stepwise reactivation of the
Ca2+ pump with ATP, in the presence of IPS3 (Fig. 1,
top), cannot be explained under the asumption that 1PS3
opens Ca2+ release channels. This is simply because the
Ca2+ pump rate would have to increase by a factor of 103
to overcome effilux rate due to the constant activation of
release channels by 1PS3. It is therefore likely that a
separate channel, presumably of low conductance and/or
low density, would be responsible for the IPS3-induced
release seen in the Ca2+ electrode experiments. That
lP3-induced release could be mediated by a receptor other
than the ryanodine receptor is not surprising. The purified
1P3 receptor is a 260-kDa protein (Supattapone et al.,
1988), dissimilar to the 567-kDa ryanodine receptor
(Takeshima et al., 1989; Furuichi et al., 1989). Further-
more, in smooth muscle microsomes, the 45Ca2+ efflux
rate through Ca2+ release channels was -10 times larger
than the lP3-induced Ca2" release (Watras et al., 1989).
Thus, the kinetics of both release mechanisms are quite
distinct, and at least in smooth muscle, they appear to be
mediated by entirely different channels (Ehrlich and
Watras, 1988).
Differences between frog and
rabbit release channels
A direct effect of IP3 on Ca2` release channels was
described by Suarez-Isla et al. (1988) in frog SR, albeit at
high Ca2` and IP3 concentrations. In their study, 50,M
IP3 (purchased from Calbiochem) could open release
channels from P0 - 0.10 to P0 - 0.85 with a half-maximal
dose of 15 ,uM IP3 at a cytosolic free Ca2+ of 40 IuM. This
result differs substantially from those summarized in
Table 1. Essentially, we found weak effects of IP3 at
micromolar Ca2+ and notoriously small effects at physio-
logical resting levels of Ca2+ and MgATP. However,
there are differences in recording solutions that should be
mentioned. Suarez-Isla et al., (1988) used 37 mM trans
(lumenal) Ca2+ or Ba2" as current carrier whereas we
kept trans Ca2+ at 10,M. Low trans Ca2+ prevented
Ca2+-dependent inactivation which drastically decreases
P0 even when the cis Ca2+ was kept in the micromolar
range (Ma et al., 1988b). For example, in 10 AM cis Ca2+
the P0 was -0.2 (Table 1) whereas in their controls at the
same cis Ca2+, activity was virtually null (P. - 0.03, Fig.
3 A of Suarez-Isla et al., 1988). Therefore, it could be
argued that the IP3 sensitivity of the release channel is
increased when the channel is inactivated by high trans
Ca2+. We considered this possibility unlikely because in
previous experiments IP3 had no effect in rabbit release
channels in high trans Ca2+, either in the absence of Cs+
(Smith et al., 1986a) or in the presence of the CsCl
solutions used in the present work (not shown). Cs' itself
did not inhibit IPS3 induced release in the Ca2+ electrode
assay (not shown). Thus, neither the absence of high trans
Ca2+ nor the presence of Cs+ may entirely account for the
difference in IP3 sensitivity between the frog and the
rabbit release channels. One hypothesis is that the IP3
sensitivity is conferred to the SR by a putative "IP3
receptor" which in mammalian skeletal muscle would be
fairly dilute. For this to apply specifically to Ca2+ release
channels, the putative "IP3 receptor" and the ryanodine
receptor could only be loosely associated because in
sucrose gradients, the CHAPS-solubilized ryanodine
receptor migrates as an oligomer with a monomer subunit
MW of -400 KDa (Valdivia et al., 1990). In our hands,
the preparation of purified ryanodine receptors does not
have contaminants abundant enough to suggest the pres-
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ence of putative "IP3 receptor" subunits. However, a
71-kDa protein was selectively cross-linked to ryanodine
receptors in rabbit triads suggesting that loosely asso-
ciated proteins can interact with Ca2" release channels
(Chadwick et al., 1988). Thus, an "IP3 receptor" abun-
dant in amphibian muscle, but not in mammalian muscle,
may account for the comparatively higher IP3 sensitivity
reported for the frog release channel (Suarez-Isla et al.,
1988) relative to that found here for the rabbit release
channel.
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Note added in proof: No effect of 1P3 was observed by Penner, R., E.
Neher, H. Takeshima, S. Nishimura, and S. Numa (1989. Functional
expression of the calcium release channel from skeletal muscle ryano-
dine receptor cDNA. FEBS [Fed. Euro. Biochem. Soc.] Lett. 259:217-
221) in calcium release channels expressed in Chinese hamster ovary
cells transformed with rabbit ryanodine receptor cDNA. This further
suggests that ryanodine receptors and IP3 receptors of skeletal muscle
are separate proteins.
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